ICON Public Limited (NASDAQ:ICLR) Receives Consensus Recommendation of "Buy" from Analysts

ICON Public Limited (NASDAQ:ICLR - Get Free Report) has been assigned an average recommendation of "Buy" from the thirteen ratings firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $346.09.

Get ICON Public alerts:

A number of brokerages have recently issued reports on ICLR. Leerink Partners began coverage on ICON Public in a research report on Wednesday, September 18th. They set an "outperform" rating and a $379.00 target price on the stock. StockNews.com downgraded ICON Public from a "buy" rating to a "hold" rating in a report on Thursday, September 19th. Truist Financial lowered their price target on ICON Public from $383.00 to $363.00 and set a "buy" rating on the stock in a report on Monday, October 14th. Leerink Partnrs upgraded ICON Public to a "strong-buy" rating in a report on Wednesday, September 18th. Finally, Robert W. Baird lowered their price target on ICON Public from $368.00 to $340.00 and set an "outperform" rating on the stock in a report on Friday, September 20th.

Read Our Latest Report on ICLR

Institutional Trading of ICON Public

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Liontrust Investment Partners LLP lifted its position in shares of ICON Public by 19.5% in the second quarter. Liontrust Investment Partners LLP now owns 119,728 shares of the medical research company's stock worth $37,531,000 after buying an additional 19,546 shares during the last quarter. Kornitzer Capital Management Inc. KS lifted its position in shares of ICON Public by 15.9% during the 2nd quarter. Kornitzer Capital Management Inc. KS now owns 95,753 shares of the medical research company's stock worth $30,016,000 after purchasing an additional 13,163 shares during the last quarter. Sara Bay Financial acquired a new position in shares of ICON Public during the 3rd quarter worth about $1,143,000. Motco lifted its position in shares of ICON Public by 1.5% during the 1st quarter. Motco now owns 3,882 shares of the medical research company's stock worth $1,304,000 after purchasing an additional 59 shares during the last quarter. Finally, Whittier Trust Co. lifted its position in shares of ICON Public by 8.6% during the 2nd quarter. Whittier Trust Co. now owns 3,579 shares of the medical research company's stock worth $1,122,000 after purchasing an additional 284 shares during the last quarter. Institutional investors and hedge funds own 95.61% of the company's stock.

Ad Paradigm Press

[Urgent] Starlink Set For The Largest IPO In History?

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.

Click here now for the urgent details on this hidden play.

ICON Public Stock Up 0.8 %

ICLR opened at $297.72 on Friday. ICON Public has a one year low of $221.20 and a one year high of $347.72. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.31 and a current ratio of 1.31. The business's fifty day moving average is $303.72 and its two-hundred day moving average is $312.36. The company has a market cap of $24.56 billion, a price-to-earnings ratio of 36.22, a PEG ratio of 1.35 and a beta of 1.22.

ICON Public (NASDAQ:ICLR - Get Free Report) last posted its quarterly earnings data on Wednesday, July 24th. The medical research company reported $3.75 EPS for the quarter, topping analysts' consensus estimates of $3.68 by $0.07. The company had revenue of $2.10 billion for the quarter, compared to the consensus estimate of $2.14 billion. ICON Public had a return on equity of 12.06% and a net margin of 8.57%. The company's quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.96 EPS. Analysts anticipate that ICON Public will post 14.54 EPS for the current fiscal year.

About ICON Public

(Get Free Report

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.

Should you invest $1,000 in ICON Public right now?

Before you consider ICON Public, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICON Public wasn't on the list.

While ICON Public currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report